In particular, increased secretion of anti-inflammatory factors such as IL-4, IL-10, and transforming growth factor beta (TGF-β) by MSCs leads to a reduction in the inflammatory activation of microglia, which are involved in AD pathogenesis [14,15,19]. This evidence concerns the gene IL10 and Alzheimer disease.